- Home
- MDGL vs LW Comparison
MDGL vs LW Comparison
Compare MDGL & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- LW
- Stock Information
- Founded
- MDGL 2011
- LW 1950
- Country
- MDGL United States
- LW United States
- Employees
- MDGL N/A
- LW N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- LW Packaged Foods
- Sector
- MDGL Health Care
- LW Consumer Staples
- Exchange
- MDGL Nasdaq
- LW Nasdaq
- Market Cap
- MDGL 6.8B
- LW 7.4B
- IPO Year
- MDGL N/A
- LW N/A
- Fundamental
- Price
- MDGL $319.93
- LW $52.60
- Analyst Decision
- MDGL Buy
- LW Buy
- Analyst Count
- MDGL 9
- LW 12
- Target Price
- MDGL $386.29
- LW $72.17
- AVG Volume (30 Days)
- MDGL 333.2K
- LW 2.9M
- Earning Date
- MDGL 05-01-2025
- LW 04-03-2025
- Dividend Yield
- MDGL N/A
- LW 2.82%
- EPS Growth
- MDGL N/A
- LW N/A
- EPS
- MDGL N/A
- LW 2.55
- Revenue
- MDGL $180,133,000.00
- LW $6,387,400,000.00
- Revenue This Year
- MDGL $230.69
- LW $1.32
- Revenue Next Year
- MDGL $74.76
- LW $1.19
- P/E Ratio
- MDGL N/A
- LW $20.56
- Revenue Growth
- MDGL N/A
- LW N/A
- 52 Week Low
- MDGL $189.00
- LW $47.90
- 52 Week High
- MDGL $377.46
- LW $89.51
- Technical
- Relative Strength Index (RSI)
- MDGL 50.76
- LW 45.69
- Support Level
- MDGL $276.20
- LW $50.16
- Resistance Level
- MDGL $330.64
- LW $53.50
- Average True Range (ATR)
- MDGL 20.79
- LW 2.24
- MACD
- MDGL 0.06
- LW -0.30
- Stochastic Oscillator
- MDGL 76.56
- LW 24.87
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 14% of fiscal 2024 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.